+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Azithromycin"

From
From
Macrolide Antibiotics Global Market Report 2024 - Product Thumbnail Image

Macrolide Antibiotics Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Antibiotic Resistance Market Report 2025 - Product Thumbnail Image

Antibiotic Resistance Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 79 Pages
  • United Arab Emirates United Arab Emirates
From
Sulphonamides Market - Product Thumbnail Image

Sulphonamides Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Loading Indicator

Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics. Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients. The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more